{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:35:37Z","timestamp":1792888537886,"version":"4.5.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00210-026-05710-1","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T05:18:10Z","timestamp":1784265490000},"page":"21167-21180","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fosfomycin susceptibility and molecular detection of fosA-mediated resistance among gram-negative uropathogens from a tertiary care hospital in Lucknow, India"],"prefix":"10.1007","volume":"399","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-2191-0735","authenticated-orcid":false,"given":"Sandeepika","family":"Dubey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Areena Hoda","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenakshi","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"5710_CR1","doi-asserted-by":"publisher","unstructured":"Ahmad S, Jahan N, Ahmad SS, Singh N, Khatoon R (2021) A retrospective study of antimicrobial susceptibility pattern of aerobic microbial isolates from urine samples of patients attending a tertiary care hospital. J Med Sci Res 9(1):5\u201310. https:\/\/doi.org\/10.17727\/JMSR.2021\/9-2","DOI":"10.17727\/JMSR.2021\/9-2"},{"issue":"2","key":"5710_CR2","doi-asserted-by":"publisher","first-page":"01","DOI":"10.9734\/jammr\/2019\/v30i230169","volume":"30","author":"M Anand","year":"2019","unstructured":"Anand M, Sahu C, Negi A, Singh A (2019) In vitro assessment of fosfomycin: a beacon of hope in drug resistant organisms causing urinary tract infections. JAMMR 30(2):01\u201309","journal-title":"JAMMR"},{"issue":"3","key":"5710_CR3","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.ijantimicag.2011.11.012","volume":"39","author":"A Apisarnthanarak","year":"2012","unstructured":"Apisarnthanarak A, Mundy LM (2012) Carbapenem-resistant Pseudomonas aeruginosa pneumonia with intermediate minimum inhibitory concentrations to doripenem: combination therapy with high-dose, 4-h infusion of doripenem plus fosfomycin versus intravenous colistin plus fosfomycin. Int J Antimicrob Agents 39(3):271\u2013272. https:\/\/doi.org\/10.1016\/j.ijantimicag.2011.11.012","journal-title":"Int J Antimicrob Agents"},{"key":"5710_CR4","doi-asserted-by":"crossref","unstructured":"Auer S, Wojna A, Hell M. (2010) Oral treatment options for ambulatory patients with urinary tract infections caused by extended-spectrum-\u03b2-lactamase-producing E.coli. Antimicrob agents chemother 54(9): e4006-e4008","DOI":"10.1128\/AAC.01760-09"},{"issue":"2","key":"5710_CR5","doi-asserted-by":"publisher","first-page":"149","DOI":"10.4103\/iju.IJU_285_16","volume":"33","author":"S Banerjee","year":"2017","unstructured":"Banerjee S, Sengupta M, Sarker TK (2017) Fosfomycin susceptibility among multidrug - resistant, extended - spectrum beta-lactamase- producing, carbapenem-resistant uropathogens. Indian J Urol 33(2):149\u2013154. https:\/\/doi.org\/10.4103\/iju.IJU_285_16","journal-title":"Indian J Urol"},{"issue":"7","key":"5710_CR6","doi-asserted-by":"publisher","first-page":"533","DOI":"10.4103\/ijccm.IJCCM_67_18","volume":"22","author":"B Behera","year":"2018","unstructured":"Behera B, Mohanty S, Sahu S, Praharaj A (2018) In vitro activity of fosfomycin against multidrug-resistant urinary and nonurinary gram-negative isolates. Indian J Crit Care Med 22(7):533\u2013536. https:\/\/doi.org\/10.4103\/ijccm.IJCCM_67_18","journal-title":"Indian J Crit Care Med"},{"issue":"9","key":"5710_CR7","doi-asserted-by":"publisher","first-page":"5623","DOI":"10.1128\/AAC.01267-16.PMID:27401568;PMCID:PMC4997847","volume":"60","author":"M Castanheira","year":"2016","unstructured":"Castanheira M, Griffin MA, Deshpande LM, Mendes RE, Jones RN, Flamm RK (2016) Detection of mcr-1 among Escherichia coli Clinical Isolates Collected Worldwide as Part of the SENTRY Antimicrobial Surveillance Program in 2014 and 2015. Antimicrob Agents Chemother 60(9):5623\u20135624. https:\/\/doi.org\/10.1128\/AAC.01267-16.PMID:27401568;PMCID:PMC4997847","journal-title":"Antimicrob Agents Chemother"},{"key":"5710_CR8","unstructured":"Clinical and Laboratory Standards Institute. (2023). Performance standards for antimicrobial susceptibility testing. CLSI supplement M100, 34th edn. CLSI, Wayne, PA, USA."},{"key":"5710_CR9","volume-title":"Mackie & McCartney Practical Medical Microbiology","author":"JG Collee","year":"1996","unstructured":"Collee JG, Fraser AG, Marmion BP, Simmons A (1996) Mackie & McCartney Practical Medical Microbiology, 14th ed. Churchill Livingstone","edition":"14th ed."},{"issue":"Suppl. 1","key":"5710_CR10","first-page":"8","volume":"32","author":"M D\u00edez-Aguilar","year":"2019","unstructured":"D\u00edez-Aguilar M, Cant\u00f3n R (2019) New microbiological aspects of fosfomycin. Rev Esp Quimioter 32(Suppl. 1):8\u201318","journal-title":"Rev Esp Quimioter"},{"issue":"3","key":"5710_CR11","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3109\/00365548.2011.616221","volume":"44","author":"A Dinh","year":"2012","unstructured":"Dinh A, Salomon J, Bru JP, Bernard L (2012) Fosfomycin: efficacy against infections caused by multidrug-resistant bacteria. Scand J Infect Dis 44(3):182\u2013189. https:\/\/doi.org\/10.3109\/00365548.2011.616221","journal-title":"Scand J Infect Dis"},{"key":"5710_CR12","doi-asserted-by":"publisher","DOI":"10.62877\/71-ijcbs-24-25-19-71","author":"S Dubey","year":"2024","unstructured":"Dubey S, Hoda Siddiqui A, Sharma M (2024) Evaluation of fosfomycin in-vitro susceptibility among gram negative isolates from urine culture in a tertiary care hospital in Lucknow. Int J Chem Biochem Sci. https:\/\/doi.org\/10.62877\/71-ijcbs-24-25-19-71","journal-title":"Int J Chem Biochem Sci"},{"issue":"10","key":"5710_CR13","first-page":"1","volume":"57","author":"ZS Elliott","year":"2019","unstructured":"Elliott ZS et al (2019) \u2018The Role of fosA in Challenges with Fosfomycin Susceptibility Testing of Multispecies Klebsiella pneumoniae Carbapenemase-. Prod Clin Isolates 57(10):1\u20138","journal-title":"Prod Clin Isolates"},{"key":"5710_CR14","unstructured":"European Committee on Antimicrobial Susceptibility Testing (2022) Breakpoint tables for interpretation of MICs and zone diameters; version 12.0. http:\/\/www.eucast.org. Accessed 12 Apr 2022"},{"issue":"1","key":"5710_CR15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S1473-3099(09)70325-1","volume":"10","author":"ME Falagas","year":"2010","unstructured":"Falagas ME et al (2010) Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum \u03b2-lactamase producing, Enterobacteriaceae infections: a systematic review. Lancet Infect Dis 10(1):43\u201350. https:\/\/doi.org\/10.1016\/S1473-3099(09)70325-1","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"5710_CR16","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1128\/CMR.00068-15","volume":"29","author":"ME Falagas","year":"2016","unstructured":"Falagas ME, Vouloumanou EK, Samonis G, Vardakas KZ (2016) Fosfomycin. Clin Microbiol Rev 29(2):321\u2013347","journal-title":"Clin Microbiol Rev"},{"issue":"8","key":"5710_CR17","doi-asserted-by":"publisher","first-page":"4314","DOI":"10.13040\/IJPSR.0975-8232.12(8).4314-21","volume":"12","author":"MAA Faraz","year":"2021","unstructured":"Faraz MAA, Mendem S, Swamy MV, Patil S (2021) Prevalence of urinary tract infections and related antimicrobial resistance in India: a systemic review and metaanalysis. Int J Pharm Sci & Res 12(8):4314\u20134321. https:\/\/doi.org\/10.13040\/IJPSR.0975-8232.12(8).4314-21","journal-title":"Int J Pharm Sci & Res"},{"key":"5710_CR18","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1093\/jac\/dkw177","volume":"71","author":"Q Guo","year":"2016","unstructured":"Guo Q, Tomich AD, McElheny CL, Cooper VS, Stoesser N, Wang M, Sluis-Cremer N, Doi Y (2016) Glutathione-S-transferase FosA6 of Klebsiella pneumoniae origin conferring fosfomycin resistance in ESBL-producing Escherichia coli. J Antimicrob Chemother 71:2460\u20132465. https:\/\/doi.org\/10.1093\/jac\/dkw177","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"5710_CR19","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.1093\/cid\/ciq257","volume":"52","author":"K Gupta","year":"2011","unstructured":"Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG et al (2011) International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 52(5):e103\u2013e120","journal-title":"Clin Infect Dis"},{"issue":"2","key":"5710_CR20","doi-asserted-by":"publisher","first-page":"90","DOI":"10.4103\/0974-2727.119849","volume":"5","author":"V Gupta","year":"2013","unstructured":"Gupta V, Rani H, Singla N, Kaisha N, Chander J (2013) Determination of ExtendedSpectrum- \u03b2-Lactamases and AmpC production in uropathogenic isolates of Escherichia coli and susceptibility to Fosfomycin. J Lab Physicians 5(2):90\u201393","journal-title":"J Lab Physicians"},{"key":"5710_CR21","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1099\/jmm.0.062653-0","volume":"62","author":"PL Ho","year":"2013","unstructured":"Ho PL, Chan J, Lo WU, Lai EL, Cheung YY, Lau TC, Chow KH (2013) Prevalence and molecular epidemiology of plasmid-mediated fosfomycin resistance genes among blood and urinary Escherichia coli isolates. J Med Microbiol 62:1707\u20131713. https:\/\/doi.org\/10.1099\/jmm.0.062653-0","journal-title":"J Med Microbiol"},{"key":"5710_CR22","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.2147\/IDR.S251360","volume":"13","author":"Y Huang","year":"2020","unstructured":"Huang Y, Lin Q, Zhou Q, Lv L, Wan M, Gao X, Wang C, Liu J-H (2020) Identifcation of fosA10, a novel plasmid-mediated fosfomycin resistance gene of Klebsiella pneumoniae origin, in Escherichia coli. Infect Drug Resist 13:1273\u20131279. https:\/\/doi.org\/10.2147\/IDR.S251360","journal-title":"Infect Drug Resist"},{"key":"5710_CR23","doi-asserted-by":"publisher","unstructured":"Ito R et al (2017) \u2018Widespread fosfomycin resistance in Gram-negative bacteria attributable to the chromosomal fosA gene\u2019, mBio 8(4): pp. 1\u20139. https:\/\/doi.org\/10.1128\/mBio.00749-17","DOI":"10.1128\/mBio.00749-17"},{"issue":"4","key":"5710_CR24","doi-asserted-by":"publisher","first-page":"132","DOI":"10.11599\/germs.2016.1100","volume":"6","author":"BS Kalal","year":"2016","unstructured":"Kalal BS, Nagaraj S (2016) Urinary tract infections: a retrospective, descriptive study of causative organisms and antimicrobial pattern of samples received for culture, from a tertiary care setting. Germs 6(4):132\u2013138","journal-title":"Germs"},{"issue":"2","key":"5710_CR25","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/jac\/dkr466","volume":"67","author":"DE Karageorgopoulos","year":"2012","unstructured":"Karageorgopoulos DE et al (2012) Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens. J Antimicrob Chemother 67(2):255\u2013268. https:\/\/doi.org\/10.1093\/jac\/dkr466","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"5710_CR26","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1080\/14787210.2017.1410434","volume":"15","author":"I Karaiskos","year":"2017","unstructured":"Karaiskos I, Antoniadou A, Giamarellou H (2017) Combination therapy for extensively-drug resistant gram-negative bacteria. Expert Rev Anti Infect Ther 15(12):1123\u20131140. https:\/\/doi.org\/10.1080\/14787210.2017.1410434. (PMID: 29172792)","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"1","key":"5710_CR27","first-page":"1","volume":"2","author":"N Khan","year":"2016","unstructured":"Khan N, Khan MS (2016) Prevalence of antimicrobial resistance in bacterial isolates causing urinary tract infection in patients attending at IIMS&R Hospital, Lucknow. Int J Life Sci Res 2(1):1\u20138","journal-title":"International Journal of Life Sciences Research"},{"issue":"4","key":"5710_CR28","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41579-018-0055-5","volume":"18","author":"RD Klein","year":"2020","unstructured":"Klein RD, Hultgren SJ (2020) Urinary tract infections: microbial pathogenesis, host-pathogen interactions, and new treatment strategies. Nat Rev Microbiol 18(4):211\u2013226. https:\/\/doi.org\/10.1038\/s41579-018-0055-5","journal-title":"Nat Rev Microbiol"},{"key":"5710_CR29","volume-title":"Color Atlas and Textbook of Diagnostic Microbiology","author":"EW Koneman","year":"2006","unstructured":"Koneman EW, Allen SD, Janda WM, Schreckenberger PC, Winn WC (2006) Color Atlas and Textbook of Diagnostic Microbiology, 6th ed. Lippincott Williams & Wilkins","edition":"6th ed."},{"issue":"952","key":"5710_CR30","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1136\/pgmj.2004.023036","volume":"81","author":"R Kucheria","year":"2005","unstructured":"Kucheria R, Dasgupta P, Sacks S, Khan M, Sheerin N (2005) Urinary tract infections: new insights into a common problem. Postgrad Med J 81(952):83","journal-title":"Postgrad Med J"},{"issue":"3","key":"5710_CR31","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/lam.12366","volume":"60","author":"Y Ma","year":"2015","unstructured":"Ma Y, Xu X, Guo Q, Wang P, Wang W, Wang M (2015) Characterization of fosA5, a new plasmid mediated fosfomycin resistance gene in Escherichia coli. Lett Appl Microbiol 60(3):259\u2013264. https:\/\/doi.org\/10.1111\/lam.12366","journal-title":"Lett Appl Microbiol"},{"key":"5710_CR32","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG et al (2012) Multidrug resistant, extensively drug resistant and pandrug resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18:268\u2013281","journal-title":"Clin Microbiol Infect"},{"key":"5710_CR33","first-page":"2789","volume-title":"Mandell, Douglas and Benett\u2019s Principles and Practice of Infectious Diseases","author":"GL Mandell","year":"2005","unstructured":"Mandell GL, Bennett JE, Dolin R (2005) Mandell, Douglas and Benett\u2019s Principles and Practice of Infectious Diseases, 6th ed. Elsevier Churchill Livingstone, Philadelphia, pp 2789\u201395","edition":"6th ed"},{"key":"5710_CR34","doi-asserted-by":"publisher","unstructured":"Martinez M, and Silley P (2010) \u2018Antimicrobial drug resistance\u2019,. Handb Exp Pharmacol 199(January 2009): pp. 227\u2013264. https:\/\/doi.org\/10.1007\/978-3-642-10324-7_10","DOI":"10.1007\/978-3-642-10324-7_10"},{"key":"5710_CR35","doi-asserted-by":"publisher","first-page":"e732","DOI":"10.1016\/j.ijid.2011.07.007","volume":"15","author":"AS Michalopoulos","year":"2011","unstructured":"Michalopoulos AS, Livaditis IG, Gougoutas V (2011) The revival of fosfomycin. Int J Infect Dis 15:e732\u2013e739. https:\/\/doi.org\/10.1016\/j.ijid.2011.07.007","journal-title":"Int J Infect Dis"},{"issue":"4","key":"5710_CR36","doi-asserted-by":"publisher","first-page":"129","DOI":"10.4103\/0971-4065.59333","volume":"19","author":"MS Najar","year":"2009","unstructured":"Najar MS, Saldanha CL, Banday KA (2009) Approach to urinary tract infections. Indian J Nephrol 19(4):129\u2013139. https:\/\/doi.org\/10.4103\/0971-4065.59333","journal-title":"Indian J Nephrol"},{"issue":"3","key":"5710_CR37","first-page":"334","volume":"5","author":"P Pardeshi","year":"2018","unstructured":"Pardeshi P (2018) Prevalence of urinary tract infections and current scenario of antibiotic susceptibility pattern of bacteria causing UTI. Indian J Microbiol Res 5(3):334\u2013338","journal-title":"Indian J Microbiol Res"},{"issue":"6","key":"5710_CR38","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1517\/14656566.2016.1145658.PMID:26799840;PMCID:PMC4970584","volume":"17","author":"F Perez","year":"2016","unstructured":"Perez F, El Chakhtoura NG, Papp-Wallace KM, Wilson BM, Bonomo RA (2016) Treatment options for infections caused by carbapenemresistant Enterobacteriaceae: can we apply \u00abprecision medicine\u00bb to antimicrobial chemotherapy? Expert Opin Pharmacother 17(6):761\u2013781. https:\/\/doi.org\/10.1517\/14656566.2016.1145658.PMID:26799840;PMCID:PMC4970584","journal-title":"Expert Opin Pharmacother"},{"key":"5710_CR39","first-page":"13","volume":"10","author":"D Prakash","year":"2013","unstructured":"Prakash D, Saxen R (2013) Distribution and antimicrobial susceptibility pattern of bacterial pathogens causing UTI in urban community of Meerut City. J Microbiol 10:13\u201318","journal-title":"J Microbiol"},{"key":"5710_CR40","doi-asserted-by":"publisher","unstructured":"Prasada Rao CMM, Vennila T, Kosanam S, Ponsudha P, Suriyakrishnaan K, Alarfaj AA, Hirad AH, Sundaram SR, Surendhar PA, & Selvam N (2022) Assessment of Bacterial Isolates from the Urine Specimens of Urinary Tract Infected Patient. In BioMed Res Int (Vol. 2022). Hindawi Limited. https:\/\/doi.org\/10.1155\/2022\/4088187","DOI":"10.1155\/2022\/4088187"},{"issue":"8","key":"5710_CR41","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00410-17","volume":"61","author":"MA Rehman","year":"2017","unstructured":"Rehman MA, Yin X, Persaud-Lachhman MG, Diarra MS (2017) First detection of a fosfomycin resistance gene, fosA7, in salmonella enterica serovar Heidelberg isolated from broiler chickens. Antimicrob Agents Chemother 61(8). https:\/\/doi.org\/10.1128\/AAC.00410-17","journal-title":"Antimicrob Agents Chemother"},{"key":"5710_CR42","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-007363","volume":"5","author":"C Rosso-Fern\u00e1ndez","year":"2015","unstructured":"Rosso-Fern\u00e1ndez C, Sojo-Dorado J, Barriga A et al (2015) Fosfomycin versus meropenem in bacteraemic urinary tract infections caused by extended-spectrum \u03b2- lactamase-producing Escherichia coli (FOREST): study protocol for an investigator-driven randomised controlled trial. BMJ Open 5. https:\/\/doi.org\/10.1136\/bmjopen-2014-007363","journal-title":"BMJ Open"},{"key":"5710_CR43","doi-asserted-by":"publisher","DOI":"10.7860\/jcdr\/2022\/52109.16161","author":"C Sahu","year":"2022","unstructured":"Sahu C, Singh S, Patel SS, Yaduvanshi N, Singh S, Ghoshal U (2022) Susceptibility profile and clinical response of fosfomycin and other antibiotics against multidrug resistant Gram negative urinary isolates: a cross-sectional study. J Clin Diagn Res. https:\/\/doi.org\/10.7860\/jcdr\/2022\/52109.16161","journal-title":"J Clin Diagn Res"},{"key":"5710_CR44","doi-asserted-by":"publisher","first-page":"7355","DOI":"10.1128\/AAC.01071-15","volume":"59","author":"S Sastry","year":"2015","unstructured":"Sastry S, Clarke LG, Alrowais H, Querry AM, Shutt KA, Doi Y (2015) Clinical appraisal of fosfomycin in the era of antimicrobial resistance. Antimicrob Agents Chemother 59:7355\u20137361. https:\/\/doi.org\/10.1128\/AAC.01071-15","journal-title":"Antimicrob Agents Chemother"},{"key":"5710_CR45","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2021\/46408.15012","author":"S Sharma","year":"2021","unstructured":"Sharma S, Verma PK, Rawat V, Negi UV (2021) Fosfomycin sensitivity pattern among uropathogens isolated from patients visiting day care facility of Sushila Tiwari Hospital in Kumaun Region Uttarakhand India. J Clin Diagn Res. https:\/\/doi.org\/10.7860\/JCDR\/2021\/46408.15012","journal-title":"J Clin Diagn Res"},{"issue":"9","key":"5710_CR46","doi-asserted-by":"publisher","first-page":"5598","DOI":"10.1128\/AAC.02435-13","volume":"58","author":"R Sirijatuphat","year":"2014","unstructured":"Sirijatuphat R, Thamlikitkul V (2014) Preliminary study of colistin versus colistin plus fosfomycin for treatment of carbapenem-resistant Acinetobacter baumannii infections. Antimicrob Agents Chemother 58(9):5598\u20135601. https:\/\/doi.org\/10.1128\/AAC.02435-13","journal-title":"Antimicrob Agents Chemother"},{"issue":"03","key":"5710_CR47","doi-asserted-by":"publisher","first-page":"e249","DOI":"10.4103\/JLP.JLP_27_19","volume":"11","author":"S Sreenivasan","year":"2019","unstructured":"Sreenivasan S, Kali A, Charles MP, Kunigal S (2019) Evaluation of in vitro susceptibility of fosfomycin among Enterobacteriaceae isolates from urine cultures: A study from Puducherry. Journal of Laboratory Physicians 11(03):e249\u2013e252","journal-title":"Journal of Laboratory Physicians"},{"issue":"4","key":"5710_CR48","first-page":"140","volume":"4","author":"S Srivastava","year":"2018","unstructured":"Srivastava S, Singh N, Sahai S, Srivastava M (2018) Aerobic bacterial profile and antimicrobial resistance in bacterial isolates causing urinary tract infection in patients attending at integral institute of medical sciences and research hospital Lucknow. Int J Med Health Res 4(4):140\u2013146","journal-title":"Int J Med Health Res"},{"issue":"1","key":"5710_CR49","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.4103\/0974-7796.148585","volume":"7","author":"A Sultan","year":"2015","unstructured":"Sultan A, Rizvi M, Khan F, Sami H, Shukla I, Khan HM (2015) Increasing antimicrobial resistance among uropathogens: is fosfomycin the answer? Urol Ann 7(1):e26\u2013e30","journal-title":"Urol Ann"},{"key":"5710_CR50","doi-asserted-by":"publisher","unstructured":"Takahata S et al (2010) \u2018Molecular mechanisms of fosfomycin resistance in clinical isolates of Escherichia coli\u2019,. Int J Antimicrob Agents. Elsevier B.V., 35(4), pp. 333\u2013337. https:\/\/doi.org\/10.1016\/j.ijantimicag.2009.11.011","DOI":"10.1016\/j.ijantimicag.2009.11.011"},{"issue":"12","key":"5710_CR51","doi-asserted-by":"publisher","first-page":"3630","DOI":"10.1093\/jac\/dkz380","volume":"74","author":"T ten Doesschate","year":"2019","unstructured":"ten Doesschate T, Abbott IJ, Willems RJL, Top J, Rogers MRC, Bonten MM, Paganelli FL (2019) In vivo acquisition of fosfomycin resistance in Escherichia coli by fosA transmission from commensal fora. J Antimicrob Chemother 74(12):3630\u20133632. https:\/\/doi.org\/10.1093\/jac\/dkz380","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"5710_CR52","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.ijantimicag.2016.02.001","volume":"47","author":"KZ Vardakas","year":"2016","unstructured":"Vardakas KZ, Legakis NJ, Triarides N, Falagas ME (2016) Susceptibility of contemporary isolates to fosfomycin: a systematic review of the literature. Int J Antimicrob Agents 47(4):269\u2013285. https:\/\/doi.org\/10.1016\/j.ijantimicag.2016.02.001","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"5710_CR53","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jmii.2017.10.006","volume":"52","author":"TY Yang","year":"2017","unstructured":"Yang TY, Lu PL, Tseng SP (2017) Update on fosfomycin-modified genes in Enterobacteriaceae. J Microbiol Immunol Infect 52(1):9\u201321. https:\/\/doi.org\/10.1016\/j.jmii.2017.10.006","journal-title":"J Microbiol Immunol Infect"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05710-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05710-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05710-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:02:10Z","timestamp":1792886530000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05710-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":53,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["5710"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05710-1","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"assertion":[{"value":"18 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}